SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-21-006162
Filing Date
2021-12-07
Accepted
2021-12-07 16:32:07
Documents
58
Period of Report
2021-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q avid_i10q-103121.htm   iXBRL 10-Q 731331
2 FIRST AMENDMENT TO THE AVID BIOSERVICES, INC. 2018 OMNIBUS INCENTIVE PLAN avid_ex1001.htm EX-10.1 5535
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER avid_ex3101.htm EX-31.1 10588
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER avid_ex3102.htm EX-31.2 10497
5 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER avid_ex3200.htm EX-32 6179
  Complete submission text file 0001683168-21-006162.txt   4184216

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdmo-20211031.xsd EX-101.SCH 28414
7 XBRL CALCULATION FILE cdmo-20211031_cal.xml EX-101.CAL 47067
8 XBRL DEFINITION FILE cdmo-20211031_def.xml EX-101.DEF 126095
9 XBRL LABEL FILE cdmo-20211031_lab.xml EX-101.LAB 282112
10 XBRL PRESENTATION FILE cdmo-20211031_pre.xml EX-101.PRE 236858
11 EXTRACTED XBRL INSTANCE DOCUMENT avid_i10q-103121_htm.xml XML 637050
Mailing Address 2642 MICHELLE DRIVE, SUITE 200 TUSTIN CA 92780
Business Address 2642 MICHELLE DRIVE, SUITE 200 TUSTIN CA 92780 714.508.6100
Avid Bioservices, Inc. (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 211476403
SIC: 2834 Pharmaceutical Preparations